Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
Dec 11 (Reuters) - Pfizer Inc and BioNTech SE received U.S. regulatory authorization for their COVID-19 vaccine on Friday, making it the first inoculation against the new coronavirus to get a regulatory green light in the United States.The follow...
Read moreDec 11 (Reuters) - Britain became the first country to roll out the COVID-19 vaccine developed by Pfizer Inc and BioNTech on Dec. 8 after final late-stage trial results showed it was 95% effective in preventing the disease.The following is what we...
Read moreDec 11 (Reuters) - Britain became the first country to roll out the COVID-19 vaccine developed by Pfizer Inc and BioNTech on Dec. 8 after final late-stage trial results showed it was 95% effective in preventing the disease.The following is what we...
Read moreBy Maria CervantesSANTIAGO, Nov 27 (Reuters) - Peru has secured enough coronavirus vaccine to give nearly three-quarters of its population at least one dose when the immunization is available, a hopeful development for a nation with one of the hig...
Read more* Three vaccine candidates lead global race* Pharma industry group sees seven more by mid-2021* Warns against calls for compulsory licensingBy Stephanie NebehayGENEVA, Nov 27 (Reuters) - Ten COVID-19 vaccines could be available by the middle of next...
Read moreBy Arno Schuetze and Pamela BarbagliaFRANKFURT/LONDON, Nov 27 (Reuters) - Drugmaker Advanz Pharma has drawn interest from private equity funds, including U.S. buyout fund Carlyle, as its creditors are scrambling to find a new owner following a deb...
Read more* Elderly targeted first, other groups to follow throughout 2021* Vaccination will not be compulsory, Macron says* Huge task awaiting Europe (Adds details, background)By Matthias BlamontPARIS, Nov 24 (Reuters) - French President Emmanuel Macron sa...
Read more
(Sharecast News) - Inhalation-focussed contract design and manufacture organisation Vectura Group announced on Friday that the United States Court of Appeals for the Federal Circuit has denied GlaxoSmithKline's (GSK) motions for judgment as a matter of law, a new trial on infringement, and for a new trial on damages in litigation concerning Vectura's US patent 8303991.
Read more
IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials
Read moreBRUSSELS, Nov 16 (Reuters) - The European Commission will authorise on Tuesday a deal with biotech firm CureVac to secure up to 405 million doses of its potential COVID-19 vaccine, the head of the European Commission Ursula von der Leyen said on ...
Read moreGlaxo, Pfizer's HIV Tablet Treatment Gets Positive Opinion In EU
Read moreUK BROKER RATINGS SUMMARY: Barclays Raises Whitbread To Overweight
Read moreLONDON BRIEFING: Market Rally Stalls As Central Bankers Issue Caution
Read moreLONDON MARKET CLOSE: FTSE Win Streak Snapped As Vaccine Joy Subsides
Read moreNov 11 (Reuters) - Shortages of flu shots this year are not related to drugmakers ramping up production of potential COVID-19 vaccines, the head of vaccines at GlaxoSmithKline (GSK) said on Wednesday.Speaking at the Financial Times' virtual health...
Read more
Last checked at